Scientists are launching an ambitious global effort to map the “human exposome” — the lifelong mix of environmental and chemical exposures that drive most diseases. Backed by new partnerships with ...
Investment will help fuel international partnerships, scale production of its early autism diagnostic aid test - StrandDx™ASD - which is expected to become available to the public in 2024 NORTH ...
Digital art rendering of a person in profile with refracted light and colors obscuring and coloring parts of the profile. The panel provides an opportunity to engage and inform AAAS delegates on ...
NEW YORK--(BUSINESS WIRE)--LinusBio, a leader in precision exposome sequencing, today announced it raised over $16 million in Series A funding to deliver a novel platform that bridges genomics, the ...
COPENHAGEN, Denmark – November 10, 2022. Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results